Holen Sie sich die Stockscreener-App
166.39
0.43%
-0.7125
Vorhandelsmarkt:
166.80
0.4125
+0.25%
Schlusskurs vom Vortag:
$167.10
Offen:
$166.38
24-Stunden-Volumen:
581.40K
Relative Volume:
0.61
Marktkapitalisierung:
$10.11B
Einnahmen:
$4.09B
Nettoeinkommen (Verlust:
$-404.84M
KGV:
-24.66
EPS:
-6.7469
Netto-Cashflow:
$1.24B
1W Leistung:
-5.95%
1M Leistung:
+20.73%
6M Leistung:
+52.02%
1J Leistung:
+34.78%
1-Tages-Spanne:
$164.44
$167.30
1-Wochen-Bereich:
$164.44
$177.70
52-Wochen-Spanne:
$95.49
$182.99
Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile
Firmenname
Jazz Pharmaceuticals Plc
Sektor
Branche
Telefon
353-1-634-7800
Adresse
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Vergleichen Sie JAZZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JAZZ
Jazz Pharmaceuticals Plc
|
166.39 | 10.15B | 4.09B | -404.84M | 1.24B | -6.7469 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-24 | Herabstufung | UBS | Buy → Neutral |
| 2025-07-15 | Eingeleitet | Deutsche Bank | Buy |
| 2025-03-07 | Hochstufung | UBS | Neutral → Buy |
| 2025-02-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-02-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-06-05 | Eingeleitet | Goldman | Buy |
| 2024-01-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-11-27 | Herabstufung | UBS | Buy → Neutral |
| 2023-09-29 | Eingeleitet | Raymond James | Mkt Perform |
| 2023-06-12 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2022-12-09 | Hochstufung | Goldman | Neutral → Buy |
| 2022-06-14 | Eingeleitet | UBS | Buy |
| 2022-04-06 | Herabstufung | Goldman | Buy → Neutral |
| 2021-11-19 | Fortgesetzt | Goldman | Buy |
| 2021-10-07 | Fortgesetzt | Jefferies | Buy |
| 2021-10-05 | Eingeleitet | Citigroup | Buy |
| 2021-09-23 | Eingeleitet | Needham | Buy |
| 2021-05-19 | Fortgesetzt | JP Morgan | Overweight |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2021-02-05 | Bestätigt | H.C. Wainwright | Buy |
| 2021-02-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-01-29 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-16 | Eingeleitet | UBS | Buy |
| 2020-11-03 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-09 | Bestätigt | H.C. Wainwright | Buy |
| 2020-09-14 | Herabstufung | Goldman | Neutral → Sell |
| 2020-09-14 | Fortgesetzt | JP Morgan | Overweight |
| 2020-08-06 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-28 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-07-23 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-04-06 | Eingeleitet | Jefferies | Buy |
| 2020-03-12 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2020-01-08 | Eingeleitet | Goldman | Neutral |
| 2019-08-21 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2019-06-11 | Eingeleitet | Barclays | Overweight |
| 2019-03-20 | Eingeleitet | SunTrust | Buy |
| 2018-12-14 | Eingeleitet | Wolfe Research | Peer Perform |
| 2018-11-08 | Bestätigt | B. Riley FBR | Buy |
| 2018-08-08 | Bestätigt | Stifel | Buy |
| 2018-07-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-03-23 | Bestätigt | H.C. Wainwright | Neutral |
| 2018-03-19 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
Alle ansehen
Jazz Pharmaceuticals Plc Aktie (JAZZ) Neueste Nachrichten
Saturn V Capital Management LP Buys New Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Trials, Sales Wins Sends Jazz Pharmaceuticals Higher - FXEmpire
Will Jazz Pharmaceuticals plc stock pay special dividendsEarnings Beat & High Conviction Buy Zone Picks - Newser
Jazz Pharmaceuticals PLC $JAZZ Shares Purchased by Systematic Financial Management LP - MarketBeat
Is Jazz Pharmaceuticals plc (J7Z) stock attractive for growth fundsEarnings Summary Report & Real-Time Buy Signal Alerts - Newser
Why hedge funds are buying Jazz Pharmaceuticals plc stock2025 Volume Leaders & Low Drawdown Momentum Trade Ideas - Newser
What MACD trends signal for Jazz Pharmaceuticals plc (J7Z) stockPortfolio Profit Report & Expert Verified Movement Alerts - Newser
How Jazz Pharmaceuticals plc (J7Z) stock performs in easing cyclesShort Setup & Weekly Market Pulse Updates - Newser
Mackenzie Financial Corp Raises Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals PLC $JAZZ Shares Bought by Prudential Financial Inc. - MarketBeat
Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Distillate Capital Partners LLC - MarketBeat
Will Jazz Pharmaceuticals plc (J7Z) stock benefit from infrastructure billQuarterly Performance Summary & Fast Moving Market Watchlists - Newser
Will Jazz Pharmaceuticals plc (J7Z) stock outperform benchmarksQuarterly Risk Review & Expert Verified Movement Alerts - Newser
Why Jazz Pharmaceuticals plc (J7Z) stock appeals to dividend investorsPrice Action & AI Driven Stock Movement Reports - Newser
Does Jazz Pharmaceutical's Acquisition of Gentium S.p.A. Signal Investment Upside? - AOL.com
Jazz Pharmaceuticals (NASDAQ:JAZZ) Director Sells $13,780,275.00 in Stock - MarketBeat
Jazz to present pivotal phase 3 results for Ziihera in GEA at ASCO GI - Investing.com Canada
Jazz Pharmaceuticals to Present Pivotal Phase 3 Results of Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma at the 2026 ASCO Gastrointestinal Cancers Symposium - PR Newswire
Looking Into Jazz Pharmaceuticals PLC's Recent Short Interest - Benzinga
Loomis Sayles & Co. L P Trims Stock Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Is Jazz Pharmaceuticals plc stock attractive for retirement portfoliosJuly 2025 Recap & Reliable Entry Point Trade Alerts - Newser
Why Jazz Pharmaceuticals plc (J7Z) stock remains stableJuly 2025 Momentum & Fast Gain Swing Alerts - Newser
Jazz Pharmaceuticals Insider Sold Shares Worth $13,780,337, According to a Recent SEC Filing - marketscreener.com
Jazz Pharmaceuticals PLC $JAZZ Stake Boosted by Vinva Investment Management Ltd - MarketBeat
American Century Companies Inc. Has $26.85 Million Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Insomnia Therapeutics Market is Going to Boom: Strategic - openPR.com
A Look at Jazz Pharmaceuticals’s Valuation After Breakthrough Phase 3 Ziihera Trial Results - Yahoo Finance
The Bull Case For Jazz Pharmaceuticals (JAZZ) Could Change Following Breakthrough Phase 3 Ziihera Trial Results - simplywall.st
Why Jazz Pharmaceuticals May Be a Stealth Cannabis Winner - Yahoo Finance
Jazz Pharma director McSharry sells $607k in shares By Investing.com - Investing.com Australia
Jazz Pharma director McSharry sells $607k in shares - Investing.com
Jazz Pharmaceuticals Insider Sold Shares Worth $607,127, According to a Recent SEC Filing - MarketScreener
Jazz Gains From Ziihera Data, Upside Seen as Priced In, UBS Says - MarketScreener
JAZZ Downgraded to Neutral by UBS, Price Target Raised to $188 | - GuruFocus
UBS Downgrades Jazz Pharmaceuticals to Neutral From Buy, Raises Price Target to $188 From $163 - MarketScreener
Jazz Pharmaceuticals stock downgraded by UBS despite price target increase - Investing.com Nigeria
Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewswire Inc.
A Look at Jazz Pharmaceuticals's Valuation After Landmark HERIZON-GEA-01 Ziihera Trial Results - simplywall.st
JAZZJazz Pharmaceuticals plc Stock Price and Quote - Finviz
How strong is Jazz Pharmaceuticals plc stock balance sheetJuly 2025 Levels & Real-Time Stock Movement Alerts - newser.com
Jazz Pharmaceuticals Insider Sold Shares Worth $3,259,538, According to a Recent SEC Filing - MarketScreener
Cozadd Bruce C, director at Jazz Pharmaceuticals, sells $3.2 million in stock By Investing.com - Investing.com South Africa
Insider Sell: Rick Winningham Sells 5,500 Shares of Jazz Pharmac - GuruFocus
Cozadd Bruce C, director at Jazz Pharmaceuticals, sells $3.2 million in stock - Investing.com Nigeria
Iannone, Jazz Pharmaceuticals EVP, sells $1.2m in JAZZ stock By Investing.com - Investing.com South Africa
Is Jazz Pharmaceuticals plc (J7Z) stock undervalued at current priceQuarterly Growth Report & Stock Timing and Entry Methods - newser.com
Finanzdaten der Jazz Pharmaceuticals Plc-Aktie (JAZZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.10%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):